Formosa Pharmaceuticals, Inc. 6838

TWSE · Taiwan · Health Technology

TWD 25.30-0.50 (-1.94%)

Market closed· Oct 2, 2026, 5:30 AM UTC· TWD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Formosa Pharmaceuticals, Inc. 6838

TWSE · Taiwan · Health Technology

TWD 25.30-0.50 (-1.94%)

Market closed· Oct 2, 2026, 5:30 AM UTC· TWD · Data may be delayed

Company news

Yahoo FinanceJun 11, 2026

Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Samil Pharmaceuticals, Co., Ltd ("Samil", 000520.KS), for exclusive rights to the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), a patented innovative medicine for the treatment of inflammation and pain following ocular surgery in Vietnam. Samil, established in 1947, is one of the most prominent Korean manufacturers

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.